Positive impactIPO

NSE IPO listing likely tomorrow: GMP at ₹81; Share price prediction ahead of BSE debut

Mint 1 hr ago·23 Sept 2026, 10:58 am

The National Stock Exchange (NSE) is set to list its shares on the stock market tomorrow, marking a historic moment for Indian equity markets. The IPO, which closed on September 20, was subscribed 5.71 times, indicating strong investor interest. The grey market premium (GMP) of ₹81 suggests the listing price could be around ₹1,866, which is 4.54% higher than the issue price of ₹1,785.

For investors, this listing is significant as it will be the first time the NSE's shares are available for public trading. The high subscription levels and positive GMP signal strong demand, which is generally a positive indicator for a stock's debut. However, the actual listing price will depend on market conditions on the day of the listing.

Investors should watch the opening price and the volume of trading on the first day. A strong opening could indicate sustained interest, while a flat or weak opening might suggest profit booking. It is important to remember that the grey market premium is not a guarantee of the listing price.

Excerpt from Mint

The NSE IPO listing is set for 24 September at 10:00 IST, with strong demand seen as it was subscribed 5.71 times. The grey market premium indicates a potential listing price of ₹ 1,866, 4.54% above the IPO price of ₹ 1,785. The NSE IPO listing is likely to take place tomorrow (Thursday, 24 September) on the bourses…
Read the original at Mint

Key takeaways

  • Category: IPO.
  • AI reads the tone as positive (potentially bullish) for the stock.
  • Assessed as a significant, market-relevant update.

Why it matters

A meaningful update worth tracking. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at Mint.

More IPO news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.